SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-047709
Filing Date
2024-11-25
Accepted
2024-11-25 06:02:00
Documents
17
Period of Report
2024-11-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039175_form8k.htm   iXBRL 8-K 29635
2 EXHIBIT 99.1 ef20039175_ex99-1.htm EX-99.1 24163
6 graphic1.jpg GRAPHIC 18209
7 graphic2.jpg GRAPHIC 41342
8 logo1.jpg GRAPHIC 5500
  Complete submission text file 0001140361-24-047709.txt   288975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lumo-20241119.xsd EX-101.SCH 3995
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lumo-20241119_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lumo-20241119_pre.xml EX-101.PRE 16053
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20039175_form8k_htm.xml XML 4194
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35342 | Film No.: 241491769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)